| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
7,432 |
1,034 |
$1.94M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
37,220 |
33,547 |
$1.46M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,517 |
13,494 |
$795K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
6,983 |
6,888 |
$673K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,131 |
7,024 |
$633K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,234 |
7,116 |
$606K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
1,576 |
1,464 |
$538K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
39,598 |
18,717 |
$443K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,471 |
5,312 |
$432K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,424 |
15,598 |
$234K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,970 |
3,842 |
$209K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,087 |
5,324 |
$156K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,888 |
5,609 |
$152K |
| S8301 |
Infection control supplies, not otherwise specified |
14,427 |
13,117 |
$105K |
| 95180 |
|
180 |
91 |
$78K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
873 |
864 |
$73K |
| 99383 |
|
730 |
722 |
$71K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,038 |
1,033 |
$65K |
| 99381 |
|
847 |
834 |
$65K |
| 99384 |
|
452 |
451 |
$48K |
| 90461 |
|
8,784 |
7,366 |
$34K |
| 99382 |
|
328 |
327 |
$33K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,720 |
2,586 |
$19K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,404 |
1,071 |
$18K |
| 87807 |
|
1,611 |
1,564 |
$17K |
| 95117 |
|
1,954 |
876 |
$16K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
326 |
326 |
$15K |
| 97802 |
|
13,767 |
13,574 |
$10K |
| 95115 |
|
988 |
441 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
541 |
502 |
$6K |
| 96160 |
|
3,935 |
3,858 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
41 |
40 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
238 |
233 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
251 |
183 |
$3K |
| 81002 |
|
1,041 |
1,009 |
$3K |
| 94010 |
|
77 |
48 |
$2K |
| 36410 |
|
105 |
104 |
$881.88 |
| 90700 |
|
1,292 |
1,261 |
$771.53 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
96 |
85 |
$488.39 |
| 97803 |
|
13 |
13 |
$157.50 |
| 90473 |
|
48 |
40 |
$78.36 |
| 97169 |
|
918 |
913 |
$76.74 |
| 99000 |
|
6,094 |
5,924 |
$56.36 |
| 90658 |
|
286 |
286 |
$40.66 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
307 |
292 |
$30.54 |
| 90686 |
|
5,035 |
4,999 |
$20.43 |
| 92551 |
|
3,983 |
3,895 |
$15.08 |
| 94760 |
|
250 |
242 |
$11.17 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
5,995 |
5,910 |
$4.52 |
| 90677 |
|
1,599 |
1,525 |
$2.35 |
| 90651 |
|
1,753 |
1,721 |
$0.25 |
| 90734 |
|
2,791 |
2,721 |
$0.24 |
| 90620 |
|
345 |
342 |
$0.23 |
| 99001 |
|
17 |
17 |
$0.16 |
| 90715 |
|
1,486 |
1,447 |
$0.06 |
| 84030 |
|
80 |
80 |
$0.02 |
| 90670 |
|
3,355 |
3,341 |
$0.01 |
| 90633 |
|
2,928 |
2,884 |
$0.01 |
| 90723 |
|
2,380 |
2,340 |
$0.01 |
| 99177 |
|
2,033 |
2,014 |
$0.00 |
| 99173 |
|
3,907 |
3,802 |
$0.00 |
| 90710 |
|
2,435 |
2,397 |
$0.00 |
| 3725F |
|
820 |
818 |
$0.00 |
| 90707 |
|
166 |
166 |
$0.00 |
| 90671 |
|
60 |
60 |
$0.00 |
| 0486T |
|
23 |
23 |
$0.00 |
| 90681 |
|
12 |
12 |
$0.00 |
| 90685 |
|
52 |
50 |
$0.00 |
| 90696 |
|
1,389 |
1,375 |
$0.00 |
| 90647 |
|
3,673 |
3,617 |
$0.00 |
| 36416 |
|
2,667 |
2,578 |
$0.00 |
| 90698 |
|
946 |
922 |
$0.00 |
| 90680 |
|
3,102 |
3,042 |
$0.00 |
| 2000F |
|
2,600 |
2,486 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
217 |
209 |
$0.00 |
| 90716 |
|
140 |
140 |
$0.00 |
| 96127 |
|
3,773 |
3,726 |
$0.00 |
| 2010F |
|
462 |
411 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
2,563 |
2,522 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27 |
26 |
$0.00 |
| V5008 |
Hearing screening |
576 |
570 |
$0.00 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
270 |
264 |
$0.00 |
| 1036F |
|
87 |
85 |
$0.00 |
| 99174 |
|
509 |
507 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
71 |
67 |
$0.00 |
| 90697 |
|
15 |
15 |
$0.00 |
| 90747 |
|
12 |
12 |
$0.00 |
| 90744 |
|
46 |
46 |
$0.00 |